Sofosbuvir & Ledipasvir
Form: Tablet
Strength: Sofosbuvir 400 mg & Ledipasvir 90 mg
Reference Brands: Harvoni®(EU & US)
Category: Anti Viral
Sofosbuvir & Ledipasvir Tablets (400 mg/90 mg) are a powerful, once-daily combination therapy for chronic Hepatitis C. Marketed under global brands like Harvoni®, Ledifos®, and Hepcinat-LP®, this fixed-dose antiviral regimen is recommended by WHO and major liver associations. It offers high cure rates with minimal side effects across genotypes 1, 4, 5, and 6. On PharmaB2B platforms, global buyers can source WHO-GMP and USFDA-approved generic alternatives from trusted Indian manufacturers. Ideal for institutional procurement, NGO supply, and public health programs, Sofosbuvir + Ledipasvir helps scale access to life-saving HCV treatment worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Zanamivir
Strength: 5 mg/blister
Form: Inhalation powder
Reference Brands: Relenza(EU & US)
View Details Get Enquiry
Oseltamivir Phosphate Capsule
Strength: Capsule- 30 mg, 45 mg, 75 mg; Oral Suspension - 6 mg/mL (reconstituted)
Form: Capsules and Oral solution
Reference Brands: Tamiflu(EU & US)
View Details Get Enquiry
Amantadine
Strength: Tab -100 mg; Capsule- 100 mg; Oral solution - 50 mg/5 mL; Extended-release capsule (ER) - 129 mg, 193 mg
Form: Tablet; Capsule; Oral Solution and ER Capsule
Reference Brands: Symmetrel(EU & US); Osmolex ER(US), Gocovri(US)
View Details Get Enquiry
Glecaprevir + Pibrentasvir
Strength: Glecaprevir- 100 mg + Pibrentasvir - 40 mg
Form: Tablet
Reference Brands: Mavyret (US); Maviret (EU)
View Details Get Enquiry